In a inventory alternate discover right this moment (26 July), the FTSE 250 agency stated it had finalised the sale of its stake within the medical expertise agency Endomag, yielding proceeds of round $46m barely surpassing Molten’s holding worth of £35m.
Molten initially invested in Endomag in 2018 and offered extra capital to assist its progress in 2020, with funding additionally coming from Molten’s EIS and VCT funds.
Molten Ventures VCT launches as much as £40m fundraise
This exit, mixed with latest proceeds from stakes in British chipmaker Graphcore and advantages platform Perkbox, takes the corporate to o…
